Literature DB >> 12505028

The effect of drug resistance on the fitness of Mycobacterium tuberculosis.

Ted Cohen1, Ben Sommers, Megan Murray.   

Abstract

Mycobacterium tuberculosis remains a leading infectious cause of morbidity and mortality. While antibiotic resistance is cited as a potential threat to efforts aimed at controlling the spread of this pathogen, it is not clear how drug resistance affects disease dynamics. The effect of mutational events that lead to antibiotic-resistant phenotypes may or may not have a predictable effect on the fitness of drug-resistant tuberculosis strains. Here, we review the literature on laboratory studies of the fitness of drug-resistant tuberculosis, we examine the evidence from cluster studies, and we consider the effect of drug resistance on disease dynamics in mathematical models. On the basis of these diverse lines of evidence, we conclude that the fitness estimates of drug-resistant M tuberculosis are quite heterogeneous and that this variation may preclude our ability to predict future trends of this pathogen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505028     DOI: 10.1016/s1473-3099(03)00483-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  64 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

3.  [Tuberculosis miliaris ulcerosa mucosae].

Authors:  N Hodzic-Avdagic; M Meghed; T Ruzicka; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2003-04       Impact factor: 0.751

4.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

5.  Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.

Authors:  D Andes; A Forrest; A Lepak; J Nett; K Marchillo; L Lincoln
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 6.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 7.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.

Authors:  S Basu; A P Galvani
Journal:  Epidemiol Infect       Date:  2008-07-07       Impact factor: 2.451

Review 8.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

9.  Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages.

Authors:  K C Wong; W M Leong; H K W Law; K F Ip; J T H Lam; K Y Yuen; P L Ho; W S Tse; X H Weng; W H Zhang; S Chen; W C Yam
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

Authors:  Travis C Porco; Peter Oh; Jennifer M Flood
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.